Kura Oncology, Inc.
Developing precision cancer medicines
- B2B
About Kura Oncology, Inc.
A clinical-stage biopharmaceutical company developing small-molecule drug candidates targeting signaling pathways to improve outcomes for cancer patients
Key facts
- Industry
- Biotechnology Research
- Company size
- 251–1,000 employees
- Headquarters
- san diego, california, United States
- Founded
- 2014
- Revenue
- $67.5MFY2025, publicly reported
- Website
- kuraoncology.com
Kura Oncology, Inc. at a glance
Kura Oncology, Inc. is a B2B company in the Biotechnology Research industry, headquartered in san diego, california, United States.
Kura Oncology, Inc. was founded in 2014.
Kura Oncology, Inc. has 251–1,000 employees.
Kura Oncology, Inc.'s revenue is $67.5M (FY2025, publicly reported).
Selling to companies like Kura Oncology, Inc.?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies